Author

S. D. Oland

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:mouse· 3 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1

Frequent Co-Authors

A. Sher· 3 shared C. S. Clancy· 3 shared K. D. Mayer-Barber· 3 shared K. L. Hilligan· 3 shared N. L. Garza· 3 shared S. Namasivayam· 3 shared B. A. P. Lafont· 2 shared D. O'Mard· 2 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

A. Sher

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Pre-existing interferon gamma conditions the lung to mediate early control of SARS-CoV-2

K. L. Hilligan, S. Namasivayam, C. S. Clancy, P. J. Baker, S. I. Old, V. Peluf, E. P. Amaral, S. D. Oland, D. O'Mard, J. Laux, M. Cohen, N. L. Garza, B. Lafont, R. F. Johnson, C. G. Feng, , A. Sher

This study shows that pre-existing IFN-gamma responses from bacterial infection reduce SARS-CoV-2 viral loads in the lungs and protect against disease in mice.

bioRxiv · Jul 15, 2023 · PreprintImmunology

Helminth exposure protects against murine SARS-CoV-2 infection through macrophage dependent T cell activation

K. L. Hilligan, O. O. Oyesola, S. Namasivayam, N. Howard, C. S. Clancy, S. D. Oland, N. L. Garza, B. A. P. Lafont, R. F. Johnson, K. D. Mayer-Barber, A. Sher, P. Loke

This study shows that prior helminth infection reduces SARS-CoV-2 viral loads in mice by enhancing CD8+ T cell responses through macrophage-dependent mechanisms.

bioRxiv · Nov 9, 2022 · PreprintImmunology

Intravenous administration of BCG protects mice against lethal SARS-CoV-2 challenge

K. L. Hilligan, S. Namasivayam, C. S. Clancy, D. O'Mard, S. D. Oland, S. J. Robertson, P. J. Baker, E. Castro, N. L. Garza, B. A. P. Lafont, R. Johnson, F. Ronchese, K. D. Mayer-Barber, S. M. Best, A. Sher

This study shows that intravenous BCG vaccination protects mice from lethal SARS-CoV-2 infection by altering pulmonary myeloid cell function and reducing immunopathology.

bioRxiv · Aug 30, 2021Immunology